Drug intelligence / Profile preview

Mastitis (Cattle) 4 in 1 vaccine

Development stage: Preclinical
Lead developer: Indian Immunologicals
Modality: Vaccines & Immunotherapeutics
Administration: Intramuscular, Subcutaneous

Overview

Indian Immunologicals Limited is developing a multivalent vaccine, referred to as 'Mastitis (Cattle) 4 in 1', aimed at preventing bovine mastitis in dairy cattle. Bovine mastitis is an inflammatory condition of the udder, typically caused by bacterial infections, which leads to significant economic losses in the dairy industry. The vaccine is designed to elicit protective immunity against multiple mastitis-causing pathogens (suggested by the '4 in 1' designation), thereby reducing the incidence and clinical severity of the disease. It is currently in advanced stages of development within the company's animal health portfolio.

Other names: mastitis vaccine (Indian Immunologicals)bovine mastitis vaccine

Beyond the preview

Go deeper on Mastitis (Cattle) 4 in 1 vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mastitis (Cattle) 4 in 1 vaccine.

Explore the full profile